JR

Janak Rajendrabhai Patel

Active Director Director DIN 10623436
DIN 10623436 First appointment Jun 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Janak Rajendrabhai Patel

Data last updated:

Janak Rajendrabhai Patel is a Director at Shrizal Pharma Private Limited (since 2024). The company operates in Paper.

DIN 10623436
Primary Designation Director
Industry Paper
First Appointment 10 Jun 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shrizal Pharma Private Limited U21001GJ2023PTC143533
Director10 Jun 20242023Active

Board colleagues of Janak Rajendrabhai Patel

Directorship timeline

Open interactive timeline →
Shrizal Pharma Private Limited
Premium access

Shareholding and investment profile for Janak Rajendrabhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Janak Rajendrabhai Patel

Janak Rajendrabhai Patel currently holds 1 directorship: Shrizal Pharma Private Limited (Director, since 10 Jun 2024).

Janak Rajendrabhai Patel was first appointed on 10 Jun 2024 as Director at Shrizal Pharma Private Limited.

The current boards of Janak Rajendrabhai Patel's companies include Payalben Manish Patel (Shrizal Pharma Private Limited), Swetaben Hareshbhai Patel (Shrizal Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available